Kymera’s protein degrader starts Phase II trial in atopic dermatitis

cafead

Administrator
Staff member
  • cafead   Dec 08, 2023 at 11:12: AM
via Following the dosing of the first patient in Phase II atopic dermatitis trial, Kymera received a $15m milestone payment from Sanofi as part of the global licensing agreement.

article source